恩威医药：公司股东户数信息将在定期报告中披露

Core Viewpoint - Enwei Pharmaceutical (301331) will disclose shareholder information in its periodic reports, and investors are advised to pay attention to the company's announcements in designated information disclosure media [1] Group 1 - The company confirmed that shareholder account information will be included in its regular reports [1] - Investors are encouraged to monitor the company's disclosures through specified channels [1]